BiQ: Telix to Resubmit NDA for Pixclara in Q4 2025 (TLX)
BiQ: Tharimmune Moved to the Probation List (THAR)
BiQ: Tharimmune Added to the BiQAP (THAR)
BiQ: Selected Premium BiQ Chat Highlights for 08/28/25
BiQ: Notes Regarding the CRL for Zircaix (TLX)
BiQ: Selected Premium BiQ Chat Highlights for 08/20/25
Non-BiQAP Trade Notification (CAPR)
BiQ: Selected Premium BiQ Chat Highlights for 08/17/25
BiQ: BiQ Investment Philosophy
BiQ: FDA Approves Papzimeos (formerly PGN-2012) for the Treatment of RRP (PGEN)